Saturnine Gout, Redux: A Review

被引:13
作者
Dalvi, Sam R. [1 ,2 ,3 ]
Pillinger, Michael H. [1 ,2 ]
机构
[1] NYU Hosp Joint Dis, Div Rheumatol, Dept Med, New York, NY USA
[2] Dept Vet Affairs, New York Harbor Hlth Care Syst, Rheumatol Sect, Dept Med, New York, NY USA
[3] Duke Univ Hlth Syst, Div Rheumatol & Immunol, Durham, NC 27710 USA
关键词
Gout; Lead toxicity; Nephropathy; Plumbism; BLOOD LEAD LEVELS; MOONSHINE; HYPERURICEMIA; PATHOGENESIS; TOXICITY; NEPHROTOXICITY; NEPHROPATHY; PREVALENCE; PATHOLOGY; EXPOSURE;
D O I
10.1016/j.amjmed.2012.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Illicitly distilled beverages (colloquially referred to as moonshine) account for approximately one third of alcohol consumption worldwide. Moonshine is often produced in makeshift distilling units composed of old, repurposed parts, whose component elements can leach into the distillate. Consequently, the resultant beverages may inadvertently contain harmful toxins, one of which is the metal lead. One manifestation of chronic lead toxicity-from moonshine or other forms of chronic lead poisoning-is the rheumatologic entity known as saturnine gout. With the increasing prevalence of gout over the past few decades, physicians should be aware of the association of moonshine consumption or lead toxicity with gouty arthritis. In this article, we present an overview of saturnine gout, beginning with a discussion of lead poisoning in antiquity and tracing its path to modern times. The contribution of lead to human disease and the clinical features of saturnine gout are outlined. After describing the role of lead in renal insufficiency and purine metabolism, we conclude with a discussion of specific strategies to manage this clinically important form of secondary gout. (C) 2013 Elsevier Inc. All rights reserved. The American Journal of Medicine (2013) 126, 450.e1-450.e8
引用
收藏
页码:450.e1 / 450.e8
页数:8
相关论文
共 50 条
  • [21] Progress in modeling avian hyperuricemia and gout (Review)
    Wang, Linlin
    Li, Jialin
    Wang, Bo
    Yin, Xianglin
    Wei, Jinfeng
    Qiu, Hongbin
    BIOMEDICAL REPORTS, 2025, 22 (01)
  • [22] Tophaceous gout in the elderly: a clinical case review
    Bolzetta, Francesco
    Veronese, Nicola
    Manzato, Enzo
    Sergi, Giuseppe
    CLINICAL RHEUMATOLOGY, 2012, 31 (07) : 1127 - 1132
  • [23] New advances in the treatment of gout: review of pegloticase
    Reinders, Mattheus K.
    Jansen, Tim L. Th A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 543 - 550
  • [24] The anatomical pathology of gout: a systematic literature review
    Patapong Towiwat
    Ashika Chhana
    Nicola Dalbeth
    BMC Musculoskeletal Disorders, 20
  • [25] Systematic review of the prevalence of gout and hyperuricaemia in Australia
    Robinson, P. C.
    Taylor, W. J.
    Merriman, T. R.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (09) : 997 - 1007
  • [26] The anatomical pathology of gout: a systematic literature review
    Towiwat, Patapong
    Chhana, Ashika
    Dalbeth, Nicola
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (1)
  • [27] Gout and comorbidity: a nominal group study of people with gout
    Singh, Jasvinder A.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [28] Hyperuricaemia and gout: A review
    Kopke, A.
    Greeff, O. B. W.
    SOUTH AFRICAN FAMILY PRACTICE, 2010, 52 (02) : 114 - 120
  • [29] Epidemiology of Gout
    Roddy, Edward
    Choi, Hyon K.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40 (02) : 155 - +
  • [30] Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis
    Luo, Lianmin
    Xiang, Qian
    Deng, Yihan
    Zhao, Shankun
    Zhu, Zhiguo
    Liu, Yangzhou
    Wang, Jiamin
    Zhao, Zhigang
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (09) : 1527 - 1535